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Introduction: The determination of cholinesterase (ChE) activity has been commonly applied in the 
biomonitoring of exposure to organophosphate and carbamate pesticides. However, ChE activity is 
influenced by genetic factors. Integrating genotype and phenotype information in clinical laboratory 
tests would increase the accuracy of the reference values in well-defined populations.
Objective: To establish genetic-based reference values for acetylcholinesterase (AChE) and 
butyrylcholinesterase (BChE) activity in a Colombian population.
Materials and methods: A total of 397 healthy adults from Bucaramanga were included in the study. 
AChE and BChE activities were measured in blood samples by potentiometry and spectrophotometry, 
respectively. Genotyping for ACHE rs17880573 and BCHE rs1803274 was performed using the TaqMan 
allelic discrimination assay. The statistical analyses to obtain the reference values were performed with 
the MedCalc® software.
Results: Allele frequencies were 10.58% for rs17880573 A and 8.82% for rs1803274 A. People with 
genotypes rs1803274 AA and AG showed a reduction of 20.69% and 10.92% respectively in mean 
BChE activity compared to people with genotype GG. No significant differences were identified in AChE 
activity between rs17880573 alleles or genotypes. In the overall sample, the corresponding reference 
values were as follows: for AChE activity, 0.62–0.98 ΔpH/h and for BChE activity, 4796.3–10321.1 U/L 
for people carrying the allele rs1803274A and 5768.2–11180.4 U/L for people carrying the genotype 
rs1803274 GG.
Conclusion: We strongly recommend using these genetic-based reference values for ChE enzymes in 
our well-defined population in daily clinical practice.
Key words: Acetylcholinesterase, butyrylcholinesterase, reference values, organophosphorus compounds, 
carbamates, Colombia.
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Valores de referencia basados en el contexto genético de la actividad enzimática de la 
colinesterasa en una población colombiana: un paso hacia el diagnóstico personalizado
Introducción. La determinación de la actividad enzimática de la colinesterasa se utiliza comúnmente 
en la vigilancia biológica de la exposición a pesticidas organofosforados y carbamatos. Sin embargo, 
los factores genéticos afectan la actividad de la colinesterasa, por lo que la integración de la información 
sobre genotipos y fenotipos en las pruebas de laboratorio clínico, incrementaría la precisión de los 
valores de referencia.
Objetivo. Establecer los valores de referencia basados en el contexto genético para la actividad 
enzimática de la acetilcolinesterasa (AChE) y la butirilcolinesterasa (BChE), en una población 
colombiana.
Materiales y métodos. Se incluyeron 397 adultos sanos. La actividad de la acetilcolinesterasa y la de 
la butirilcolinesterasa, se determinaron en muestras de sangre por potenciometría y espectrofotometría, 
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respectivamente. Los genotipos de los ACHE rs17880573 y BCHE rs1803274 se obtuvieron mediante 
el ensayo TaqMan y los valores de referencia se estimaron con el programa MedCalc®. 
Resultados. La frecuencia alélica fue de 10,58 % para rs17880573 A y de 8,82 % para rs1803274 
A. Las personas con los genotipos rs1803274 AA y AG, mostraron una reducción en el promedio 
de la actividad de la butirilcolinesterasa de 20,69 % y de 10,92 %, respectivamente, comparados 
con aquellas con el genotipo GG. No se encontraron diferencias significativas en la actividad de la 
acetilcolinesterasa con respecto a los alelos y genotipos del rs17880573. Los valores de referencia 
determinados para esta población fueron de 0,62-0,98 ΔpH/h para acetilcolinesterasa y de 4796,3-
10321,1 U/L para butirilcolinesterasa, en las personas portadoras del alelo rs1803274 A, y de 5768,2–
11180,4 U/L, en las portadoras del genotipo rs1803274 GG.
Conclusión. Se recomienda el uso de estos valores de referencia basados en el contexto genético 
para las colinesterasas, en la práctica clínica diaria en esta población.
Palabras clave: acetilcolinesterasa, butirilcolinesterasa, valores de referencia, compuestos organo-
fosforados, carbamatos, Colombia.
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Cholinesterases, or ChE, are a family of enzymes 
that catalyse the hydrolysis of the neurotransmitter 
acetylcholine (ACh) into choline and acetic acid, an 
essential reaction necessary to allow a cholinergic 
neuron to return to the resting state after impulse 
transmission. This process is important to prevent 
an overstimulation of muscles due to the build-
up of acetylcholine in the neuromuscular junction 
and thus muscle spasms that can lead to death. 
Cholinesterases are divided into two classes based 
on differences in their substrate specificity, sus-
ceptibility to various kinds of inhibitors and tissue 
distribution: acetylcholinesterase (AChE; EC 3.1.1.7) 
and butyrylcholinesterase (BChE; EC 3.1.1.8) (1).
The determination of ChE activity has been com-
monly applied in the biomonitoring of exposure 
to organophosphate and carbamate pesticides 
(2), especially in high-risk individuals such as 
farmworkers. The progressive inhibition of AChE 
or BChE by these two pesticides may produce a 
cholinergic response, inducing bronchospasm and 
bradycardia. In Colombia, for instance, it has been 
found that the most common pesticide poisoning 
cases were due to organophosphates and car-
bamates (3). The basic clinical diagnosis due to 
the poisoning by these two pesticides is based on 
depression in the activity of serum and red blood 
cell ChE that, in turn, are based on the knowledge 
of reference ranges of these enzyme activities in 
the corresponding general population.
Laboratory reference ranges for ChE in healthy 
populations that are currently used in Colombia 
and other Latin American countries are derived 
mainly from data obtained from North American 
and European populations. However, the laboratory 
parameters vary geographically by factors such 
as ethnic origin and the altitude above sea level of 
populations, and inter-individually by demographic 
and genetic factors (4,5). Nevertheless, among 
them the genetic factors presumably play a major 
role. Thus, it is important to adjust the laboratory 
parameters of ChE accurately based on those 
factors in well-defined populations.
AChE and BChE share approximately 54% amino 
acid sequence identity. Nevertheless, in com-
parison with BChE, AChE is a highly conserved 
molecule across species (6) and only a few 
naturally occurring genetic polymorphisms have 
been reported in the human gene (7). The genetic 
variation of single nucleotide polymorphisms 
(SNPs) in these genes has been largely studied 
in relation to the onset of Alzheimer’s disease 
(8,9). There are no studies that prove SNPs in 
the ACHE gene affect AChE activity. However, 
SNPs in the BCHE gene, and especially the 
polymorphic K-variant (the A allele of the Ala539Thr 
polymorphism; rs1803274), have been shown to 
be associated with a substantial reduction in the 
catalytic activity of BChE (10). In this context, 
integrating genetic and laboratory information 
could increase the accuracy of reference intervals 
by reducing outliers related to genetic variation, 
which is a prerequisite for correct interpretation 
of toxicological findings. Therefore, in this study 
we established comprehensive genetic-based 
reference values for AChE and BChE activity in a 
Colombian population.
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Materials and methods
Population
The study included 397 healthy adults from 
Bucaramanga, Colombia, with no history of expo-
sure to ChE inhibitors and without physiological 
conditions that could affect the ChE levels such as 
pregnancy or obesity. The population of this region 
does not have a concentration of ethnical groups 
and it is not structured (11,12). Health status was 
evaluated by body mass index (BMI≥18 and ≤30) 
and blood analysis: haemoglobin, albumin and 
glutamic-pyruvate transaminase were measured 
by spectrophotometric methods according to the 
kit manufacturer’s instructions (Human; Germany). 
Subjects with abnormal liver function (serum 
albumin <3.8 g/dL and glutamic-pyruvate trans-
aminase at 37°C >32 U/I for women and >42 U/I 
for men) or haemoglobin levels (<12 g/dL or >18 g/
dL for women and >19 g/dL for men) or BMI (< 18 
or > 30) were excluded. People were also excluded 
if they had a history of anaemia, malnutrition, 
diabetes, hepatitis, thyroid disease or if they were 
taking a strong analgesic such as codeine.
Determination of cholinesterase activities
ChE activities were measured in human blood 
samples drawn after a 12-h overnight fast. People 
should not have consumed alcohol for at least 72 
hours prior to blood-sampling. Intravenous blood 
was collected in 7 mL heparin Vacutainer tubes 
(Becton-Dickinson; USA). The blood samples were 
centrifuged at 2000 rpm for 15 min within 2 hours 
of collection to separate erythrocytes and plasma 
that were used for AChE and BChE measurement, 
respectively. All specimens were processed imme-
diately after they were obtained.
Acetylcholinesterase assay. AChE-activity was 
measured by the potentiometric method described 
by Michel (13). Briefly, the erythrocytes were washed 
twice with 0.9% NaCl by repeated resuspension and 
centrifugation at 2500 rpm for 5 min. Samples were 
adjusted to a haematocrit of 50% (v/v) in isotonic 
saline solution as an erythrocyte suspension, then 
80 µl of the erythrocyte suspension were lysed 
with 1.92 mL of 0.01% saponin. One millilitre of the 
haemolysate was mixed with 1 mL of a buffer solution 
containing 0.02 M sodium barbital, 0.004 M KH2PO4 
and 0.6 M KCl of pH 8.10 at 25°C. Thereafter, the 
pH of the mixture (pH1) was measured with a glass 
electrode using a Seven EasyTM pH meter (Mettler-
Toledo International Inc.; USA), and then, 200 µl of 
0.11 M aqueous solution of acetylcholine chloride 
were added to the mixture. The reaction mixture 
was incubated at 25°C for 1 h. At the end of the 
incubation period, the pH of the reaction mixture 
(pH2) was measured. The enzyme activity was 
calculated using the following equation:
     ΔpH/hour = pH1 - pH2 - b
t
f
       equation (1), 
where the initial and final pH values correspond 
to pH1 and pH2, respectively; t is the reaction 
time (1 hour); b is the corrected value due to non-
enzymatic hydrolysis and f is the variation value of 
ΔpH/h (13).
Butyrylcholinesterase assay. BChE-activity was 
measured with a spectrophotometer equipped 
with a thermocontrolled cell-holder using the 
Selectra JR clinical chemistry analyser (Myco 
Instrumentation, Inc.; USA), and butyrylthiocholine 
(60 mmol/L) as a substrate (BioSystems, S.A.; 
Spain). The first read was done after reaction 
mixture was incubated at 37°C for 90 s, and 
then readings were taken every 30 s for 90 s. 
The enzyme activity was calculated using the 
following equation:
      U/L = ΔA/min x Vt x 10
6
ε x l x Vs            equation (2),
where the molar extinction coefficient (ε) of the 
chromogen at 405 nm is 927; l is the light-path 
(1 cm); Vt is the total volume of reaction mixture 
(1.525); Vs is the sample volume (0.025) and 1 
U/L is equivalent to 0.0166 µkat/L (BioSystems 
S.A.; Spain).
Single-nucleotide polymorphism selection and 
genotyping. Single-nucleotide polymorphisms were 
selected according to functional considerations 
and prediction as tag SNPs based on a minor allele 
frequency (MAF) ≥10% and a linkage disequilibri-
um (LD) coefficient r2 ≥0.80 using the aggressive 
tagging algorithm implemented in Haploview 4.2 
software (14). The genotype data set of European–
American ancestry [CEU] and Mexican–American 
ancestry [MEX] published in the International 
HapMap Project (15) phase 3 release 3 was used 
as the reference population.
Genomic DNA was isolated from 7 mL of EDTA-
treated blood samples using the standard 
salting-out technique (16). DNA concentration 
was measured by spectrophotometry at A260 
and A280 using a NanoDrop 2000 (Thermo 
Fisher Scientific; USA). The final concentration 
of genomic DNA was adjusted to 100 ng/µL. 
ACHE rs17880573 and BCHE rs1803274 were 
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genotyped by TaqMan allelic discrimination 
assay using a StepOnePlus™ Real-Time PCR 
(Life Technologies; USA). Allele-specific probes 
were labelled with VIC and FAM fluorescent 
dyes. The design and validation of TaqMan® SNP 
genotyping assays were performed by Applied 
BioSystems (Life Technologies; USA).
Statistical analysis
The sample size was determined based on 
an estimated population of 165,263 people in 
Bucaramanga who were between 20 and 64 years 
of age according to the Colombian Departamento 
Administrativo Nacional de Estadística (DANE). 
The minimum sample size was calculated as 390 
subjects considering a sampling error of 0.0082 
and ChE (total) population values, a significance 
level of 0.05 and a confidence interval of 95%.
Allele and genotype frequencies were determined 
by direct counting. Genotype frequency deviation 
from Hardy-Weinberg equilibrium was estimated 
using the Markov chain random-walk algorithm 
implemented in Arlequin 3.11 software (17). A p-value 
<0.05 was considered as evidence of deviation 
from Hardy–Weinberg equilibrium. Statistical com-
parisons of ChE activities among different alleles, 
genotypes, sex, and age-groups were performed 
by the use of ANOVA or an unpaired T-test using 
the software Stata 10.0 (18). The smoothed local 
regression (loess) curves were used to examine 
the effect of sex and age on AChE and BChE 
activity levels. A variance partitioning analysis was 
performed as an exploratory method to assess the 
usefulness of partitioning. A difference between 
subpopulation averages ≥40% of the subsample 
standard deviations (Eq. 3) and a proportion 
of the total variance attributable to the genetic 
polymorphism ≥4% (Eq. 4) were the criteria 
considered for justifying the partitioning (19) using 
the following equations:
  = 
(x1 - x2) 3
σt 2 77 (p2 + 2pq) (q2) 
      equation (3) and
        ≥ 0.04
(a1 - a2) (x1 - x2)2 
σt 2                  equation (4),
where x1 and x2 are the average of the analyte 
in each subgroup, and a1 and a2 are the relative 
proportions of each subgroup with respect to the 
total group; σt and σt2 are the standard deviation 
and variance of the analyte concentration in the 
total group, respectively; q represents the minor 
allele frequency of the polymorphism and p the 
frequency of the common allele (19).
Reference intervals, defined as the central 95% 
of the population (2.5th-97.5th percentiles), were 
calculated based on normal distribution following 
the International Federation of Clinical Chemistry 
& Laboratory Medicine (IFCC) recommendations 
reported in the guidelines C28-A2 and C28-A3 for 
estimating percentiles and their 90% confidence 
intervals as set by the Clinical and Laboratory 
Standards Institute (CLSI). The statistical analysis 
used to obtain the reference values were performed 
with MedCalc® v13.1.0 software (20).
Ethical considerations
This study complied with the Colombian Medical 
Code of Ethics and it has been performed in 
accordance with the ethical standards laid down 
in the 1964 Declaration of Helsinki. The Scientific 
Investigation Committee on Medical Ethics of the 
Universidad Industrial de Santander approved the 
research protocol. All subjects were enrolled in the 
study following informed consent.
Results
Socio-demographic and health characteristics of 
the participants are summarized in table 1. A rela-
tive frequency distribution shows the proportion of 
women and men according to ChE activity values in 
figure 1. In the overall sample, the AChE and BChE 
activity values follow an approximately normal 
distribution with a mean ± standard deviation of 
0.776 ± 0.083 ΔpH/hour (95% CI from 0.767 to 
Table 1. Demographic and health characteristics of study population
Parameter
Women (N=203) Men (N=194)
Mean ± SD Range Mean ± SD Range
Age (years)
BMI
Haemoglobin (g dL-1)
Albumin (g dL-1)
GPT (U/L)
36.65 ± 12.03
23.36 ±   2.82
14.34 ±   1.24
  4.58 ±   0.25
15.68 ±   5.69
(18-63)
(18.08-29.78)
(12.02-17.78)
(3.80-5.20)
(5.0-32.0)
36.62 ± 12.59
24.36 ±   2.70
15.70 ±   1.38
  4.72 ±   0.24
24.45 ±   8.55
(18-63)
(18.15-29.75)
(12.30-18.96)
(4.20-5.20)
(6.0-42.0)
* BMI: body mass index; GPT: glutamic-pyruvate transaminase
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0.784) and 8397.09 ± 1412.88 U/L (95% CI from 
8254.46 to 8539.71), respectively. The distributions 
of AChE and BChE activity levels according to 
age and sex are illustrated in figure 2. Sex had a 
significant effect on BChE activity (T-test p<0.0001; 
95% CI from -1143.59 to -610.21) but not on AChE 
activity (T-test p=0.84), with men showing higher 
mean levels than women (figure 2). In addition, 
the AChE and BChE activity in men tended to rise 
until age 30-45 where it then leveled off, as can be 
observed in the smoothing curves (figure 2). 
Frequency of genotypes and alleles of the SNPs and 
ChE activities are presented in table 2. The gen-
otype frequencies for both SNPs were distributed 
in accordance with the Hardy-Weinberg equilibrium 
(ACHE rs17880573: χ2=0.59; p=0.444, and BCHE 
rs1803274: χ2=1.43; p=0.232). No differences in 
AChE activity between ACHE rs17880573 alleles 
and among genotypes were identified (T-test 
p=0.53). However, in BChE activity a statistically 
significant difference was identified between BCHE 
rs1803274 alleles (T-test p<0.0001; 95% CI from 
621.02 to 1376.36) and among genotypes (ANOVA-
test, p<0.001). People with genotype rs1803274 
AA and AG showed a reduction of 20.69% and 
10.92% respectively in mean BChE activity as 
compared to people with genotype GG (table 2 
and figure 3).
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Figure 1. Stacked column graphs represent the relative frequency of values for AChE and BChE activities in women (grey) and 
men (black). 
Figure 2. Less smoothing curves of AChE and BChE activity values depending on age and sex. Data are represented as follows: 
White circles and solid line, women; black squares and dashed line, men. The figure shows that both age and sex had effect on 
BChE activity but not on AChE activity. However, this effect was only significant in the sex (T-test p<0.0001; 95% CI from -1143.59 
to -610.21), with men showing higher mean levels than women.
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The partitioning analysis by genetic variant showed 
that the average BChE activity differed between 
BCHE rs1803274 subpopulations by 70.6% and 
that this SNP could explain 6.38% of the total 
variance of the enzymatic activity under a model 
of dominant inheritance (figure 4). Therefore, the 
genetic effect of this polymorphism is large enough 
to justify the partitioning of the population into two 
subpopulations: BCHE rs1803274 A (AA + AG) and 
GG. Partitioning by sex and age was justified based 
on the T-test and ANOVA-test results (table 2). 
Reference values are presented in table 3. These 
reference values were determined considering the 
differences found in the enzyme activity in terms of 
sex, age and genetic variation.
Discussion
Laboratory reference values based on genetic 
information would increase the accuracy of correct 
identification of pathological conditions by eliminat-
ing results related to genetic variation. The reference 
values reported in this study are a combination of 
both individual and population level approaches 
that can be used to help improve the diagnosis and 
treatment of poisoning caused by the handling of 
organophosphate and carbamate pesticides, as 
well as to evaluate sensitivity to succinylcholine 
prior to surgical procedure. To our knowledge, this 
is the first report in the literature performed with the 
aim of establishing reference values for the AChE 
and BChE enzyme activities based on genetic 
variants in a Colombian population.
Prior publications have reported reference values 
for AChE and BChE enzyme activities in Colombia. 
However, as was expected, our values were found 
to be different to the ranges previously published 
in the department of Antioquia, Colombia (4,21). 
These differences are related mainly to variation 
in geographic, demographic and genetic factors, 
as well as in the laboratory techniques used; 
hence, the results are difficult to compare. Michel, 
EQM® and Monotest®, for instance, were the 
methods used to quantify the enzymatic activity in 
these studies; each method reports the enzymatic 
activity using different units of measurement. 
Moreover, and although only the last two are 
commercial tests (which in principle means that 
they are standardised), the Michel method was 
not adequately described; e.g. there is no infor-
mation about the substrate itself, i.e., was it 
acetylcholine chloride or bromide? Or were the 
samples processed fresh or after freezing? These 
and others variables do influence the results (22) 
and, as a consequence, the reference values.
Table 2. Genotype and allele frequencies of ACHE and BCHE polymorphisms and AChE and BChE activity values
SNP, sex and age
Frequency ACHE (ΔpH/h) and BCHE (U/L) activities
p value
N=397 (%) Mean ± SD Range
ACHE rs17880573
AA
AG
GG
A
G
Women
Men
18-30 years
31-45 years
≥46 years
BCHE rs1803274
AA
AG
GG
A
G
Women
Men
18-30 years
31-45 years
≥46 years
3
78
316
84
710
203
194
151
140
106
5
60
332
70
724
203
194
151
140
106
(0.75)
(19.65)
(79.60)
(10.58)
(89.42)
(51.13)
(48.87)
(38.04)
(35.26)
(26.70)
(1.26)
(15.11)
(83.63)
(8.82)
(91.18)
(51.13)
(48.87)
(38.04)
(35.26)
(26.70)
0.72 ± 0.07
0.78 ± 0.07
0.78 ± 0.09
0.78 ± 0.07
0.78 ± 0.08
0.78 ± 0.08
0.78 ± 0.08
0.76 ± 0.07
0.79 ± 0.09
0.79 ± 0.09
6787.2 ± 1780.7
7623.0 ± 1372.9
8557.4 ± 1359.5
7558.7 ± 1409.4
8414.4 ± 1400.9
7965.4 ± 1262.3
8842.3 ± 1430.5
7960.6 ± 1335.1
8477.7 ± 1451.2
8900.4 ± 1296.4
(0.68-0.80)
(0.63-0.92)
(0.60-1.02)
(0.63-0.92)
(0.60-1.02)
(0.61-1.02)
(0.60-1.02)
(0.61-1.02)
(0.61-1.02)
(0.60-0.99)
(4487-8695)
(3995-10624)
(5484-11508)
(3995-10624) 
(3995-11508)
(4487-10729)
(3995-11508)
(4487-11508)
(3995-11399)
(5982-11274)
0.479
0.5348
0.8401
<0.001a
<0.0001a
  <0.0001b
<0.0001c.
<0.001a
a ANOVA test
b t-test, 95% CI from 633.98 to 1363.39
c t-test, 95% CI from 610.99 to 1142.81
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Figure 4. Partitioning BChE activity values by use of proportions 
of variance due to the rs1803274 polymorphism. The solid line 
represents the cut-off for partitioning by genetic variation effects 
under a dominant model of inheritance. The difference in means 
and SD of the total sample and the minor allele frequency for 
rs1803274 (AA + AG) is represented by a triangle. Partitioning 
using a sample recruited randomly from the population is 
justifiable because our result falls in the area above the curve.
Figure 3. Box-percentile plot to compare the AChE and BChE activity values for rs17880573 and rs1803274, respectively, according 
to genotype and allele. Statistical significance is represented by an asterisk: t-test p<0.001.
Geographically, Bucaramanga is situated on a 
plateau in the Cordillera Oriental of the Colombian 
Andes at an altitude of 959 meters (3,146 feet) 
above sea level. This, in comparison with the 
other studies, is more than 500 and up to 1200 
meters difference in elevation. Altitude is a well-
known non-physiological parameter that affects 
red blood cell count, the source of AChE in blood. 
Regarding the demographic and genetic factors, it 
is important to note that the population from this 
region does not have a concentration of ethnic 
groups and it is not structured (11,12), meaning 
that it has one subpopulation that is the population 
itself. Thus, in principle, any consideration based 
on genetic parameters applies to the population 
level. Therefore, it is reasonable to believe that 
the results presented in this article are an accurate 
representation of Bucaramanga’s population.
There is no information about the effect of the 
ACHE rs17880573 polymorphism on AChE activity. 
This SNP was chosen because it was the tag SNP 
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Table 3. Reference intervals for AChE and BChE activity partitioned by allele, sex and age
Allele/Sex/Age N
Normal
p valuea
95% Reference interval
Lower limit (90% CI) Upper limit (90% CI)
AChE (ΔpH/h)
Entire sample
≤30 years
31-45 years
≥60 years
BChE (U/L)
Entire sample
Allele A (AA + AG) rs1803274
- Women
- Men
- 18-30 years
- 31-45 years
- ≥46 years
Allele G (GG) rs1803274
- Women
- Men
- 18-30 years
- 31-45 years
- ≥46 years
397
151
140
106
397
65
35
30
25
18
22
332
168
164
126
122
84
0.014
0.009
0.408
0.339
0.074
0.804
0.796
0.659
0.104
0.499
0.495
0.024
0.536
0.041
0.423
0.349
0.418
0.62
0.63
0.61
0.62
5638.3
4796.3
4815.3
5022.5
5169.5
3848.9
5710.7
5768.2
5747.8
6252.5
5475.3
6105.1
6617.4
(0.61-0.64)
(0.61-0.66)
(0.59-0.63)
(0.59-0.65)
(5484.0-5972.0)
(4295.7-5296.9)
(4227.9-5402.7)
(4224.0-5821.0)
(4560.8-5778.1)
(2698.2-4999.8)
(4906.2-6515.1)
(5619.0-6121.0)
(5480.3-6015.3)
(5625.0-6701.0)
(5133.9-5816.7)
(5766.0-6444.2)
(6227.4-7007.4)
0.98
0.89
0.97
0.96
11123.4
10321.1
9550.2
10972.1
9299.9
10438.9
10821.9
11180.4
10509.0
11346.5
10733.9
11243.9
11515.5
(0.92-0.99)
(0.89-1.02)
(0.95-0.99)
(0.94-0.99)
(10750.0-11315.0)
(9820.4-10821.8)
(8962.8-10137.5)
(10173.6-11770.6)
(8691.2-9908.5)
(9288.1-11589.7)
(10017.4-11626.3)
(10957.0-11351.0)
(10241.5-10776.5)
(11150.0-11508.0)
(10392.6-11075.3)
(10904.8-11582.9)
(11125.6-11905.5)
a D’Agostino-Pearson test. Normality is rejected when p value is less than 0.05, then the reference intervals were calculated using a non-
parametric percentile method according to the CLSI C28-A3 guidelines.
with the highest minor allele frequency (15%) in 
the CEU population according to the HapMap 
and because it maps closely to the regulatory 
region of the ACHE gene and, hence, it could be 
a marker for the regulation of this gene. However, 
no significant difference in the AChE activity was 
observed with respect to the SNP rs17880573 
(figure 3 and table 2). 
In the case of BChE activity, it is well known that 
the BCHE rs1803274 polymorphism (nucleotide 
substitution G>A) determines an amino acid 
change from Ala (GCA) to Thr (ACA) at residue 539 
(K variant) located in the C-terminal tetramerization 
domain of BChE. Contradictory findings have been 
reported for the effects of this polymorphism on the 
catalytic properties of the enzyme: Peptides with 
the C-terminal sequence carrying the K-variant 
exhibited similar (23) and different (24) enzymatic 
activity, protein folding and tetramer formation. 
Thus, more experimental evidence is needed to 
clear up these biochemical inconsistencies. Be that 
as it may, it has been reported that individuals with 
Thr/Thr genotype have a reduced BChE activity of 
about 30% (10). However, although a significant 
difference in the BChE activity was observed with 
the SNP rs1803274, our experimental evidence 
shows that subjects with genotype rs1803274 AA 
and AG showed a reduction in mean BChE activity 
of 20.69% and 10.92%, respectively, compared to 
subjects with genotype GG (figure 3 and table 2). 
These differences could be explained, at least in 
part, by the patterns of linkage disequilibrium with 
other SNPs such as rs1799807 (10) and rs1126680 
(25), which impact the enzymatic activity by affecting 
the affinity for cholinesterase inhibitors (26) and 
the level of BChE expression (27), respectively. 
Regarding this, there is epidemiological evidence 
from a body mass index study in Brazil that suggests 
that the lower BChE activity associated with the 
SNP rs1803274 is strongly influenced by the SNP 
rs1126680 (27). However, if this were true in our 
population, it would not have a significant impact 
on the reference values reported here; on the one 
hand, because the SNP rs1803274 is globally 
more frequent according to the NCBI dbSNP 
(MAF 0.16 vs 0.035), being 0.088 the MAF found 
in our population (table 2), and on the other hand, 
because the majority of chromosomes bearing the 
SNP rs1126680 also carry the SNP rs1803274 
due to the strong linkage disequilibrium (D’ > 90%) 
between these two SNPs (27). 
The results of the BChE enzyme activity by 
genotype clearly suggest an additive effect of the 
rs1803274 polymorphism (table 2 and figure 3). 
Thus, the partitioning strategy should be based 
on the genotypes. However, due to the low 
frequency of individuals being homozygous for 
this polymorphism (table 2) a dominant model of 
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inheritance was assumed, because individuals 
with the genotype AG and GG represent the vast 
majority of the total population (19). 
In conclusion, for the first time we have established 
sex and age-related normal ranges for the enzyme 
activity of AChE and BChE based on genetic 
polymorphisms. We believe that this approximation 
is an important step toward personalised medicine. 
In this way, we strongly recommend using these 
reference values from our well-defined population 
in daily clinical practice not only at hospital level, 
but also at occupational level.
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